Jeparilon 10 chewable tablets

Jeparilon, 10 chewable tablets

Description

Jeparilon is a combination chewable tablet containing Famotidine (10 mg), Calcium Carbonate (800 mg), and Magnesium Hydroxide (165 mg). It is used for the short-term symptomatic relief of heartburn, acid indigestion, hyperacidity, and related digestive discomfort. Its dual action reduces stomach acid and neutralizes it, providing fast and effective relief.

Indications for Use

Short-term symptomatic relief of:

Heartburn

Indigestion

Acid indigestion

Hyperacidity

Directions for Use and Dosage

Adults and children ≥16 years of age:

Chew one tablet for symptom relief

Do not exceed two tablets in 24 hours

Maximum treatment duration: 6 consecutive days

Do not start another course without consulting a doctor or pharmacist

Method of Administration:

For oral use

Chew tablet thoroughly before swallowing

Contraindications

-Hypersensitivity to famotidine, calcium carbonate, magnesium hydroxide, or any excipients

-Cross-sensitivity to other H₂-receptor antagonists

-Moderate to severe renal failure

-Severe hepatic impairment

Precautions

-Consult a physician before use if you:

-Are taking other medications

-Suffer from other illnesses

-Have pre-existing hypercalcaemia or hypermagnesaemia

-Seek medical advice before use if:

-You are over 50 and experiencing new or changed symptoms

-You experience symptoms such as weight loss, anemia, difficulty swallowing, or chest pain

-Discontinue use and consult a doctor if symptoms persist, worsen, or include severe vomiting, black stools, or choking

Not suitable for individuals with:

Fructose intolerance

Glucose-galactose malabsorption

Sucrase-isomaltase deficiency

Lactase insufficiency

Galactosaemia

Side Effects

Blood and lymphatic system disorders:

Rare: Leukopenia, Pancytopenia

Immune system disorders:

Rare: Anaphylactic reaction, Hypersensitivity

Metabolism and nutrition disorders:

Rare: Decreased appetite

Psychiatric disorders:

Not known: Nervousness

Nervous system disorders:

Common: Headache

Uncommon: Dizziness, Dysgeusia (taste disturbance), Somnolence

Rare: Paraesthesia

Gastrointestinal disorders:

Uncommon: Abdominal discomfort, pain, diarrhea, dry mouth, flatulence, nausea, vomiting, oropharyngeal discomfort/pain

Rare: Constipation, upper abdominal pain, abdominal distension, abnormal stools, dyspepsia, eructation (belching), thirst

Hepatobiliary disorders:

Rare: Cholestatic jaundice, liver disorders

Skin and subcutaneous tissue disorders:

Uncommon: Rash

Rare: Angioedema, Pruritus, Urticaria

Very rare: Alopecia

Musculoskeletal disorders:

Rare: Arthralgia

Reproductive system and breast disorders:

Rare: Gynecomastia

General disorders and administration site conditions:

Uncommon: Asthenia, fatigue

Rare: Malaise

Investigations:

Rare: Abnormal liver enzyme levels

Pregnancy and Lactation

Pregnancy:

Use only if the expected benefit to the mother outweighs the potential risk to the fetus, as adequate studies in pregnant women are lacking.

Lactation:

Famotidine is excreted in human milk. Magnesium salts may also pass into breast milk and potentially cause diarrhea in infants. A decision must be made to discontinue either breastfeeding or therapy, weighing benefits and risks.

Storage Conditions

Store below 30°C in a dry place

Keep out of reach of children

Packaging

Carton box containing 5 blister strips, each with 2 chewable tablets, and an insert leaflet.